Related Experiment Video
Updated: Jul 8, 2026

Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
Published on: July 30, 2016
Investigating the efficacy, methods, and challenges of induced pluripotent stem cells (iPSC) therapy in Parkinson's
Mohammed Ahmed Mustafa1, Shaker Al-Hasnaawei2,3, Irwanjot Kaur4
1Department of Biology, College of Education, University of Samarra, Samarra, 34010, Iraq.
Abstract:
Neurodegenerative disorders like Parkinson's disease (PD) are defined by the gradual degeneration of neurons across various regions of the central nervous system, which ultimately leads to brain dysfunction in the affected patients. The utilization of stem cell-based approaches, encompassing fetal ventral mesencephalic cells, human embryonic stem cells (hESCs), and human induced pluripotent stem cells (hiPSCs), holds great promise for PD patients. The modeling of neurodegenerative diseases using stem cells provides a valuable platform to screen potential therapeutic agents and investigate disease mechanisms. However, the common clinical use of stem cell therapies is hindered by related ethical concerns, the risk of immunological rejection, and the lack of established grafting protocols. The conversion of differentiated adult cells into induced pluripotent stem cells (iPSCs) has sparked renewed optimism for the progress of cell-based replacement therapeutic approaches. This review highlights the recent progress in the application of stem cell technologies, specifically the utilization of hiPSCs, for the treatment of PD. Additionally, the review discusses the potential of hiPSCs in PD, which can facilitate the translation of iPSC-based approaches into clinical settings for PD treatment.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
iPS Cell Differentiation
EPS and iPS Cells in Disease Research

